RT Journal Article
SR Electronic
T1 Model calibration, nowcasting, and operational prediction of the COVID-19 pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.14.20065227
DO 10.1101/2020.04.14.20065227
A1 J. D. Annan
A1 J. C. Hargreaves
YR 2020
UL http://medrxiv.org/content/early/2020/05/27/2020.04.14.20065227.abstract
AB The COVID-19 pandemic has already caused huge human and economic cost, and will likely continue to do so for some time. Accurate and timely forecasting is essential in order for policy-makers to anticipate future requirements so that they may plan and respond effectively. We present a model-based nowcasting and forecasting system based on calibration of a dynamical epidemic model to observational data. We apply Bayesian model calibration and initialisation methods that are well established in other fields, but that do not appear to have been used in the UK in the current outbreak. We show that it would have been possible using our methods to diagnose and forecast the rapid growth of the COVID-19 outbreak in the UK by mid-March. We also show that model calibration can successfully estimate the effect of the lockdown policies in various European countries, deducing correctly that the reproduction number was likely less than 1 around three weeks after the lockdown date. This is significantly earlier than has been achieved by other approaches. Our current (16 May) estimate for the reproduction number in the UK is R = 0.8 with a 95% range of 0.7−0.9.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was obtained for this workAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets and code used for the current study are available from the corresponding author on reasonable request. Example code used for the analysis is available on GitHub. https://github.com/epimath/cm-dag